Pathology Industry in Asia Countries Market Research & Statistics

You might be interested in: vaccine, drug, hospital, more »

About 5 200 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in India

  • Original Research Article
  • October 2014
    5 pages
  • Anaemia  

  • India  

View report >

Pathology Description in India

  • Original Research Article
  • October 2014
    5 pages
  • Anaemia  

    Blood Disease  

  • India  

View report >

Pathology Description in India - Forecast

  • Original Article: Online Ahead of Publication
  • October 2014
    5 pages
  • Diabete  

  • India  

View report >

Pathology Description in China

  • Hengyi Mao, Wenzhe Ma, Hongyan Lu, Lu Wang, Hui Zheng, Yingying ...
  • October 2014
    11 pages
  • Pathology  

    Hiv  

  • China  

View report >

Pathology Description in Saudi Arabia

  • Preventing Chronic Disease
  • October 2014
    10 pages
  • Obesity  

  • Saudi Arabia  

View report >

Pathology Description in Pakistan

  • Original Article
  • October 2014
    9 pages
  • Diabete  

  • Pakistan  

View report >

Pathology Description in Taiwan

  • Preventing Chronic Disease
  • October 2014
    10 pages
  • Chronic Conditi...  

  • Taiwan  

View report >

Pathology Description in Pakistan

  • Original Article
  • October 2014
    6 pages
  • Pathology  

    Diabete  

  • Pakistan  

View report >

Pathology Description in Japan

  • Changes in Coronary Heart Disease Risk among Japanese
  • September 2014
    6 pages
  • Pathology  

  • Japan  

View report >

Pathology Description in Turkey and the US - Forecast

  • Thrombolysis for Acute Myocardial Infarction
  • September 2014
    16 pages
  • Pathology  

  • Turkey  

    United States  

View report >

Search in Pathology Industry

About 600 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 55 - $ 4 995)

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • September 2014
  • by Global Data

PharmaPoint: HER2-Positive Breast Cancer - Japan Drug Forecast and Market Analysis to 2023 Summary HER2-positive breast cancer is the second most common cancer in the world and the most common cancer in ...

Pharmapoint: Her2-positive Breast Cancer - China Drug F ...

September 2014 $ 4 995

Non-hodgkin Lymphoma Therapeutics In Asia-pacific Marke ...

September 2014 $ 4 995

Epicast Report: Dyslipidemia - Epidemiology Forecast To ...

October 2014 $ 3 995

Epicast Report: Breast Cancer (her2-, Her2+) - Epidemio ...

September 2014 $ 3 995

Epicast Report: Renal Cell Carcinoma - Epidemiology For ...

August 2014 $ 3 995

Herceptin (her2-positive Breast Cancer) - Forecast And ...

September 2014 $ 3 495

Perjeta (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Kadcyla (her2-positive Breast Cancer) - Forecast And Ma ...

September 2014 $ 3 495

Tykerb (her2-positive Breast Cancer) - Forecast And Mar ...

September 2014 $ 3 495


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.